| Literature DB >> 31974217 |
Ken C Pang1,2,3,4, Lauren Notini1,5, Rosalind McDougall6, Lynn Gillam6,7, Julian Savulescu1,8, Dominic Wilkinson8, Beth A Clark9, Johanna Olson-Kennedy10, Michelle M Telfer1,2, John D Lantos11.
Abstract
Many transgender and gender-diverse people have a gender identity that does not conform to the binary categories of male or female; they have a nonbinary gender. Some nonbinary individuals are most comfortable with an androgynous gender expression. For those who have not yet fully progressed through puberty, puberty suppression with gonadotrophin-releasing hormone agonists can support an androgynous appearance. Although such treatment is shown to ameliorate the gender dysphoria and serious mental health issues commonly seen in transgender and gender-diverse young people, long-term use of puberty-suppressing medications carries physical health risks and raises various ethical dilemmas. In this Ethics Rounds, we analyze a case that raised issues about prolonged pubertal suppression for a patient with a nonbinary gender.Entities:
Year: 2020 PMID: 31974217 DOI: 10.1542/peds.2019-1606
Source DB: PubMed Journal: Pediatrics ISSN: 0031-4005 Impact factor: 7.124